These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18632924)

  • 1. Measurement of the humoral immune response following an incident human papillomavirus type 16 or 18 infection in young women by a pseudovirion-based neutralizing antibody assay.
    Steele J; Collins S; Wen K; Ryan G; Constandinou-Williams C; Woodman CB
    Clin Vaccine Immunol; 2008 Sep; 15(9):1387-90. PubMed ID: 18632924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine: final analysis of a long-term follow-up study up to 9.4 years post-vaccination.
    Naud PS; Roteli-Martins CM; De Carvalho NS; Teixeira JC; de Borba PC; Sanchez N; Zahaf T; Catteau G; Geeraerts B; Descamps D
    Hum Vaccin Immunother; 2014; 10(8):2147-62. PubMed ID: 25424918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of two different assay kits for the detection of secreted alkaline phosphatase in HPV antibody neutralization assays.
    Kemp TJ; Matsui K; Shelton G; Safaeian M; Pinto LA
    Hum Vaccin Immunother; 2015; 11(2):337-46. PubMed ID: 25695397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age distribution of human papillomavirus infection and neutralizing antibodies in healthy Chinese women aged 18-45 years enrolled in a clinical trial.
    Wei LH; Su YY; Hu YM; Li RC; Chen W; Pan QJ; Zhang X; Zhao FH; Zhao YQ; Li Q; Hong Y; Zhao C; Li MQ; Liu WY; Li CH; Guo DP; Ke LD; Lin BZ; Lin ZJ; Chen S; Sheng W; Zheng ZZ; Zhuang SJ; Zhu FC; Pan HR; Li YM; Huang SJ; Zhang J; Qiao YL; Wu T; Xia NS
    Clin Microbiol Infect; 2020 Aug; 26(8):1069-1075. PubMed ID: 31904566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of seropositivity among HPV-16/18 DNA positive young women.
    Porras C; Bennett C; Safaeian M; Coseo S; Rodríguez AC; González P; Hutchinson M; Jiménez S; Sherman ME; Wacholder S; Solomon D; van Doorn LJ; Bougelet C; Quint W; Schiffman M; Herrero R; Hildesheim A;
    BMC Infect Dis; 2010 Aug; 10():238. PubMed ID: 20698998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between direct ELISA, single epitope-based inhibition ELISA and pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16/18 cervical cancer vaccine.
    Dessy FJ; Giannini SL; Bougelet CA; Kemp TJ; David MP; Poncelet SM; Pinto LA; Wettendorff MA
    Hum Vaccin; 2008; 4(6):425-34. PubMed ID: 18948732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between ELISA and pseudovirion-based neutralisation assay for detecting antibodies against human papillomavirus acquired by natural infection or by vaccination.
    Zhao H; Lin ZJ; Huang SJ; Li J; Liu XH; Guo M; Zhang J; Xia NS; Pan HR; Wu T; Li CG
    Hum Vaccin Immunother; 2014; 10(3):740-6. PubMed ID: 24384608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concordance assessment between a multiplexed competitive Luminex immunoassay, a multiplexed IgG Luminex immunoassay, and a pseudovirion-based neutralization assay for detection of human papillomaviruse types 16 and 18.
    Brown D; Müller M; Sehr P; Pawlita M; Seitz H; Rubio I; Antonello J; Radley D; Roberts C; Saah A
    Vaccine; 2014 Oct; 32(44):5880-7. PubMed ID: 25148777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of human papillomavirus DNA and antibody positivity in young males and females, suggesting a site-specific natural course of infection.
    Vriend HJ; Bogaards JA; van der Klis FR; Scherpenisse M; Boot HJ; King AJ; van der Sande MA;
    PLoS One; 2013; 8(4):e60696. PubMed ID: 23637760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and predictors of human papillomavirus-6, -11, -16, and -18 infection in young norwegian women.
    Kim S; Arduino JM; Roberts CC; Marsico M; Liaw KL; Skjeldestad FE
    Sex Transm Dis; 2011 Jul; 38(7):587-97. PubMed ID: 21301390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The seroprevalence of IgG antibodies to human papillomavirus (HPV) types HPV-16, HPV-18, and HPV-11 capsid-antigens in mothers and their children.
    Marais DJ; Sampson CC; Urban MI; Sitas F; Wiliamson AL
    J Med Virol; 2007 Sep; 79(9):1370-4. PubMed ID: 17607783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of neutralizing antibodies and DNA of human papillomavirus 16, 18 in women aged 18-45 years in Funing, Jiangsu province].
    Liu W; Wei F; Tang J; Yang S; Gao Y; Wang T; Jiang Y; Li M; Hong Y; Chu K; Chen W; Hu Y; Zhu F
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Mar; 37(3):406-9. PubMed ID: 27005547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More men than women make mucosal IgA antibodies to Human papillomavirus type 16 (HPV-16) and HPV-18: a study of oral HPV and oral HPV antibodies in a normal healthy population.
    Marais DJ; Sampson C; Jeftha A; Dhaya D; Passmore JA; Denny L; Rybicki EP; Van Der Walt E; Stephen LX; Williamson AL
    BMC Infect Dis; 2006 Jun; 6():95. PubMed ID: 16762074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial.
    Apter D; Wheeler CM; Paavonen J; Castellsagué X; Garland SM; Skinner SR; Naud P; Salmerón J; Chow SN; Kitchener HC; Teixeira JC; Jaisamrarn U; Limson G; Szarewski A; Romanowski B; Aoki FY; Schwarz TF; Poppe WA; Bosch FX; Mindel A; de Sutter P; Hardt K; Zahaf T; Descamps D; Struyf F; Lehtinen M; Dubin G;
    Clin Vaccine Immunol; 2015 Apr; 22(4):361-73. PubMed ID: 25651922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the immunogenicity and reactogenicity of Cervarix and Gardasil human papillomavirus vaccines in HIV-infected adults: a randomized, double-blind clinical trial.
    Toft L; Storgaard M; Müller M; Sehr P; Bonde J; Tolstrup M; Østergaard L; Søgaard OS
    J Infect Dis; 2014 Apr; 209(8):1165-73. PubMed ID: 24273179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years.
    Schwarz TF; Huang LM; Valencia A; Panzer F; Chiu CH; Decreux A; Poncelet S; Karkada N; Folschweiller N; Lin L; Dubin G; Struyf F
    Hum Vaccin Immunother; 2019; 15(7-8):1970-1979. PubMed ID: 31268383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection.
    Simen-Kapeu A; Kataja V; Yliskoski M; Syrjänen K; Dillner J; Koskela P; Paavonen J; Lehtinen M
    Scand J Infect Dis; 2008; 40(9):745-51. PubMed ID: 19086247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of newly detected infections and cervical abnormalities in adult women seropositive or seronegative for naturally acquired HPV-16/18 antibodies.
    Rosillon D; Baril L; Del Rosario-Raymundo MR; Wheeler CM; Skinner SR; Garland SM; Salmeron J; Lazcano-Ponce E; Vallejos CS; Stoney T; Ter Harmsel B; Lim TYK; Quek SC; Minkina G; McNeil SA; Bouchard C; Fong KL; Money D; Ilancheran A; Savicheva A; Cruickshank M; Chatterjee A; Fiander A; Martens M; Bozonnat MC; Struyf F; Dubin G; Castellsagué X
    Cancer Med; 2019 Aug; 8(10):4938-4953. PubMed ID: 31273942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: a partially-blind randomised placebo-controlled study.
    Denny L; Hendricks B; Gordon C; Thomas F; Hezareh M; Dobbelaere K; Durand C; Hervé C; Descamps D
    Vaccine; 2013 Nov; 31(48):5745-53. PubMed ID: 24091311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Serological Epidemiological Survey of Antibodies against 4 HPV Subtypes in Uygur Women in Xinjiang.
    Husaiyin S; Han L; Mamat H; Husaiyin K; Wang L; Niyazi M
    Jpn J Infect Dis; 2016 Jul; 69(4):273-8. PubMed ID: 26255734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.